Potenza Therapeutics, Inc. — Form D
Potenza Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-29. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-12-29
- Form: D
- Accession: 0001627187-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 5
- Date of first sale: 2017-12-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-301945
Issuer
- Name: Potenza Therapeutics, Inc.
- CIK: 0001627187
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1030 MASSSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
- Phone: 617-588-4150
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Luke Evnin | Director | Watertown, MA |
| Daniel Hicklin | Director | Cambridge, MA |
| Shunichiro Matsumoto | Director | Cambridge, MA |
| Arnold Oronsky | Director | BOSTON, MA |
| David Cordo | Executive Officer | Cambridge, MA |
| Daniel Hicklin | Executive Officer | Cambridge, MA |
| Reid Leonard | Executive Officer | Cambridge, MA |
| Cynthia Seidel-Dugan | Executive Officer | Cambridge, MA |
| Sakae Asanuma | Director | Cambridge, MA |
| Phil Gutry | Director | Baltimore, MD |
| James Wescott | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More